Sumatriptan
- Product NDC
- 36000-289
- 11-digit product format
- 360000289
- Labeler code
- 36000
- Product ID
- 36000-289_62c6c207-3e07-498e-ac5c-2f6e1a632a7e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sumatriptan
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- Baxter Healthcare Corporation
- Application
- ANDA207101
- Marketing category
- ANDA
- Marketing start
- 2023-01-19
- Substance
- SUMATRIPTAN SUCCINATE
- Active strength
- 6 mg/.5mL
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 36000-289-25 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 36000-289-05 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 36000-289-10 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 36000-289-25 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 36000-289-05 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 36000-289-10 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207101-001 | SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | SOLUTION / SUBCUTANEOUS | 2023-01-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | SOLUTION / SUBCUTANEOUS | 2023-01-19 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | SOLUTION / SUBCUTANEOUS | 2023-01-19 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2023-01-19 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2023-01-19 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | AP | 2023-01-19 | 053a50430f4f… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A207101-001 | SUMATRIPTAN SUCCINATE | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | INJECTABLE / SUBCUTANEOUS | 2023-01-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207101-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207101-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A207101-001 | AP | 1 | 053a50430f4f… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sumatriptan
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SUMATRIPTAN SUCCINATE | 6 mg/.5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| J8BDZ68989 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 313165 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| d13df081-648c-44c0-9854-5a1bfe23ae89 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 59adc2ba-d5f0-4a52-b35a-cc77921a79d2 | Product name | 4 | 20250724 |
| 2839c963-7eb3-970a-287f-ff1b6d381268 | Product name | 2 | 20250103 |
| 1e973b2d-e028-69cd-9258-4613ba80fdc5 | Product name | 3 | 20210512 |
| 3eb481d3-8b69-436f-82dd-4a66345568ab | Product name | 1 | 20190611 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| c100f0c7-e9dd-42f4-b0a8-0d81bd2a877c | Product name | 1 | 20160303 |
| 49615343-b619-4365-8118-8f2ed6046e78 | Product name | 1 | 20160224 |
| a6319377-430a-43db-82f9-30d1d9d89cf8 | Product name | 1 | 20151216 |
| f6199b09-e585-7ceb-4b09-803cf5ce1ed1 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 36000-289-05 | Sumatriptan | 0.5 mL in 1 VIAL | INJECTION | 0.5 | 5 | |
| 36000-289-05 | Sumatriptan | 5 in 1 CARTON | INJECTION | 5 | 5 | |
| 36000-289-10 | Sumatriptan | 10 in 1 CARTON | INJECTION | 10 | 5 | |
| 36000-289-10 | Sumatriptan | 0.5 mL in 1 VIAL | INJECTION | 0.5 | 5 | |
| 36000-289-25 | Sumatriptan | 0.5 mL in 1 VIAL | INJECTION | 0.5 | 5 | |
| 36000-289-25 | Sumatriptan | 25 in 1 CARTON | INJECTION | 25 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sumatriptan | SUMATRIPTAN | Baxter Healthcare Corporation | d13df081-648c-44c0-9854-5a1bfe23ae89 | 2026-01-28 | Warnings, Adverse reactions | 207101 ANDA207101 36000-289 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 313165 | SUMAtriptan 6 MG in 0.5 ML Injection | PSN | d13df081-648c-44c0-9854-5a1bfe23ae89 | 5 |
| 313165 | 0.5 ML sumatriptan 12 MG/ML Injection | SCD | d13df081-648c-44c0-9854-5a1bfe23ae89 | 5 |
| 313165 | sumatriptan (as sumatriptan succinate) 12 MG/ML Injection | SY | d13df081-648c-44c0-9854-5a1bfe23ae89 | 5 |
| 313165 | sumatriptan 6 MG per 0.5 ML Injection | SY | d13df081-648c-44c0-9854-5a1bfe23ae89 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 36000-289-05 | 36000028905 | 5 VIAL in 1 CARTON (36000-289-05) / .5 mL in 1 VIAL | 5 vial | 2023-01-19 | No | No | Current |
| 36000-289-10 | 36000028910 | 10 VIAL in 1 CARTON (36000-289-10) / .5 mL in 1 VIAL | 10 vial | 2023-01-19 | No | No | Current |
| 36000-289-25 | 36000028925 | 25 VIAL in 1 CARTON (36000-289-25) / .5 mL in 1 VIAL | 25 vial | 2023-01-19 | No | No | Current |